NASDAQ · PPH
VanEck Pharmaceutical ETF
$119.33+$2.41 (+2.06%)
VanEck Pharmaceutical ETF’s quoted price sits in the upper half of its reported 52-week range, 1.27% below the high.
Loading market information…
AMEX · DFSB · USD
Stock price, dividends
Quote as of Oct 30, 2026, 07:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Dimensional - Global Sustainability Fixed Income ETF’s quoted price sits in the lower half of its reported 52-week range, 5.42% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Dimensional - Global Sustainability Fixed Income ETF’s forward annual dividend is $0.89 per share, paid monthly. The forward yield is 1.77% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
This exchange-traded fund primarily allocates capital to a diverse collection of high-quality fixed income instruments. These securities, which encompass mortgage-backed bonds, originate from both domestic and international corporate and governmental entities. To be considered 'investment grade,' they must possess a credit rating of at least BBB- from S&P or Fitch, or Baa3 from Moody's. A core principle of this portfolio is its sustainable investment strategy, which leads to the exclusion or reduced weighting of debt issued by certain corporations and non-sovereign governmental bodies, based on their environmental, social, and governance impact.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 10:32 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$119.33+$2.41 (+2.06%)
VanEck Pharmaceutical ETF’s quoted price sits in the upper half of its reported 52-week range, 1.27% below the high.
$58.82-$0.76 (-1.28%)
JPMorgan U.S. Value Factor ETF’s quoted price sits in the upper half of its reported 52-week range, 3.0% below the high.
$44.22+$0.17 (+0.37%)
DoubleLine Opportunistic Core Bond ETF’s quoted price sits in the lower half of its reported 52-week range, 6.01% below the high.
$66.71-$0.57 (-0.84%)
Longview Advantage ETF’s quoted price sits in the upper half of its reported 52-week range, 2.11% below the high.
$38.58-$2.13 (-5.23%)
REX FANG & Innovation Equity Premium Income ETF’s quoted price sits in the lower half of its reported 52-week range, 20.83% below the high.
$29.90-$0.36 (-1.18%)
SMI 3Fourteen REAL Asset Allocation ETF’s quoted price sits in the upper half of its reported 52-week range, 2.72% below the high.
$20.02+$0.04 (+0.2%)
First Trust Intermediate Duration Investment Grade Corporate ETF’s quoted price sits in the lower half of its reported 52-week range, 6.36% below the high.
$46.24-$0.03 (-0.06%)
Pacer Aristotle Pacific Floating Rate High Income ETF’s quoted price sits in the lower half of its reported 52-week range, 3.02% below the high.
